Active, not recruitingNot applicableNCT02384733
Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost
Studying OBSOLETE: Lymphedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Danish Breast Cancer Cooperative Group
- Principal Investigator
- Lars Stenbygaard, MDAalborg University Hospital
- Intervention
- Loco-regional RT(radiation)
- Enrollment
- 2963 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2015 – 2032
Study locations (1)
- Aarhus University Hospital, Aarhus, Denmark
Collaborators
Danish Cancer Society
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02384733 on ClinicalTrials.govOther trials for OBSOLETE: Lymphedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06912763Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)M.D. Anderson Cancer Center
- ACTIVE NOT RECRUITINGNANCT06521268Effects of Inspiratory Muscle Training on LymphedemaBiruni University
- RECRUITINGNANCT05962827Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LYCentre Hospitalier Universitaire de Nice
- ACTIVE NOT RECRUITINGNANCT05682885The Effectiveness of Lymphatic Bypass SupermicrosurgeryDharmais National Cancer Center Hospital
- ACTIVE NOT RECRUITINGNANCT05441943Lymphaticovenous Anastomosis as Treatment for LymphedemaOdense University Hospital